| abstract |
The present invention relates to a compound having the formula (I) [wherein R represents a (C 1 -C 6 ) alkyl group, a halo (C 1 -C 6 ) alkyl group; R1 represents a hydrogen atom, (C 1 -C 6) alkyl group; R2 is, (i) hydroxy group is substituted with one or more groups selected from (C 1 -C 6) alkoxy groups, halo (C 1 -C 6) (C 1 -C 6 ) alkyl group optionally substituted with an alkyl group, (ii) one or more hydroxy groups, (C 1 -C 6 ) alkoxy groups, hydroxy (C 1 -C 6 ) alkyl groups An optionally substituted heterocyclic group; (iii) an optionally substituted heterocyclic (C 1 -C 6 ) alkyl group substituted with one or more hydroxy groups; R 3 and R 4 are a hydrogen atom, halogen, (C 1 -C 6) alkyl group, halo (C 1 -C 6) Al Group, represents (C 1 -C 6) alkoxy groups, halo (C 1 -C 6) alkoxy or respectively one or more atoms or phenyl group which may be substituted with a group selected from cyano; Y is a hydrogen atom, halogen, (C1-C6) alkyl groups, halo (C 1 -C 6) alkyl group, (C 1 -C 6) alkoxy groups, halo (C 1 -C 6) alkoxy groups, (C 1 - C 6 ) represents alkyl S (O) p or cyano; p is between 0 and 2. ], The compound takes the form of a base or acid addition salt. The invention also relates to methods for preparing the compounds and therapeutic uses of the compounds. |